<bill session="115" type="h" number="6240" updated="2023-01-11T13:42:17Z">
  <state datetime="2018-06-27">REFERRED</state>
  <status>
    <introduced datetime="2018-06-27"/>
  </status>
  <introduced datetime="2018-06-27"/>
  <titles>
    <title type="display">Drug Discount Accountability Act</title>
    <title type="official" as="introduced">To amend the Public Health Service Act to provide for certain user fees under the 340B drug discount program.</title>
    <title type="short" as="introduced">Drug Discount Accountability Act</title>
  </titles>
  <sponsor bioguide_id="C001092"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2018-06-27"/>
  </cosponsors>
  <actions>
    <action datetime="2018-06-27">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-06-27" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Employee hiring"/>
    <term name="Government employee pay, benefits, personnel management"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Inflation and prices"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-07T21:34:31Z" status="Introduced in House">Drug Discount Accountability Act

This bill requires the Health Resources and Services Administration to collect a user fee from certain entities participating in the 340B drug pricing program, including critical access hospitals, for activities relating to program oversight and improvement.</summary>
</bill>
